Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3ESVL | ISIN: US0287191029 | Ticker-Symbol:
NASDAQ
26.04.24
19:37 Uhr
4,000 US-Dollar
+0,110
+2,83 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
AMERICAN ONCOLOGY NETWORK INC Chart 1 Jahr
5-Tage-Chart
AMERICAN ONCOLOGY NETWORK INC 5-Tage-Chart

Aktuelle News zur AMERICAN ONCOLOGY NETWORK Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoAmerican Oncology Network: American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and Nevada1
MoAmerican Oncology Network, Inc. - 8-K, Current Report1
04.04.Central Georgia Cancer Care Joins American Oncology Network to Elevate Local Cancer Care Delivery1
03.04.American Oncology Network Expands to Hawaii, Welcomes New Practice to Network1
28.03.American Oncology Network, Inc. - 8-K, Current Report-
28.03.American Oncology Network GAAP EPS of -$0.76, revenue of $324.2M1
28.03.American Oncology Network, Inc. ("AON") Announces Fourth Quarter and Full Year 2023 Financial Results65Fiscal Year 2023 Revenue was $1,279.2 million, an 11.3% increase over 2022 Patient encounter growth of 7.9% as compared to the prior fiscal year Fourth Quarter 2023 Revenue was $324.2 million, a 7.9%...
► Artikel lesen
26.02.American Oncology Network to Present at Cowen Annual Health Care Conference1
06.02.American Oncology Network: Cancer and Blood Specialists of Georgia Opens New Oncology Clinic in Cumming-
11.01.Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting371FLORHAM PARK, N.J., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization...
► Artikel lesen
21.12.23Physicians from American Oncology Network Selected to Present at the American Society of Hematology Annual Meeting and Exposition1
27.11.23American Oncology Network, Inc. - S-8, Securities to be offered to employees in employee benefit plans1
27.11.23American Oncology Network, Inc. - 8-K, Current Report1
18.11.23American Oncology Network, Inc. - S-1/A, General form for registration of securities-
14.11.23American Oncology Network, Inc. - 10-Q, Quarterly Report-
14.11.23American Oncology Network reports Q3 results1
14.11.23American Oncology Network, Inc. Announces Third Quarter 2023 Financial Results231Third Quarter 2023 Highlights Revenue of $336.3 million increased by 13.1% compared to the prior year quarter.Successfully transitioned to a publicly traded company with the completion of our business...
► Artikel lesen
14.11.23American Oncology Network, Inc. - 8-K, Current Report1
07.11.23American Oncology Network's Specialty Pharmacy Reports Zero Drug Waste After Value-Based Trial, Secures Unchanged Reimbursement Rate for 20241
02.11.23American Oncology Network Launches New Cancer Foundation1
Seite:  Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1